Literature DB >> 9069515

Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study.

J T Powell1, R J Edwards, P C Worrell, P J Franks, R M Greenhalgh, N R Poulter.   

Abstract

PURPOSE AND
METHOD: A hospital based case-control study was designed to investigate what aspects of smoking and what co-factors of smoking are associated with the development of peripheral arterial disease (PAD). Cases were 291 smokers, newly referred with PAD, and controls were 828 age and sex matched smokers without PAD.
RESULTS: Reported recent tobacco usage was similar in cases and controls but total tobacco exposure was associated with the risk of PAD-adjusted odds ratios (ORs) increasing with tertile of pack-years smoked to reach 1.63 (95% CI, 1.11-2.39; P = 0.011), for the highest tertile ( > 48 pack-years) compared with smokers in the lowest tertile (< 31 pack-years). Cases reported smoking significantly lower tar and nicotine yield cigarettes than controls, but tended to inhale more deeply, and had significantly higher plasma concentrations of cotinine. ORs for PAD were significantly and independently increased by systolic blood pressure > 160 mmHg (8.1 (5.2 13.0); P < 0.0001), history of hypertension (2.4 (1.5-3.2); P = 0.0003) and apolipoprotein B > 0.9 g/l(3.8 (2.3-7.6); P = 0.008).
CONCLUSIONS: Increased total exposure to tobacco and the ability to smoke tobacco in a way which maximises nicotine yield are associated with increased risk of smokers developing PAD. There is no evidence that smoking low tar cigarettes reduces this risk, whereas both hypertension (particularly systolic) and high levels of apolipoprotein B, increase this risk.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9069515     DOI: 10.1016/s0021-9150(96)06012-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.

Authors:  Joe F Lau; Mitchell D Weinberg; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

2.  Peripheral artery disease: current insight into the disease and its diagnosis and management.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

3.  Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.

Authors:  M J Thun; D M Burns
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

Review 4.  Cigarette smoking, endothelial injury and cardiovascular disease.

Authors:  R Michael Pittilo
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

5.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Authors:  Thorgeir E Thorgeirsson; Frank Geller; Patrick Sulem; Thorunn Rafnar; Anna Wiste; Kristinn P Magnusson; Andrei Manolescu; Gudmar Thorleifsson; Hreinn Stefansson; Andres Ingason; Simon N Stacey; Jon T Bergthorsson; Steinunn Thorlacius; Julius Gudmundsson; Thorlakur Jonsson; Margret Jakobsdottir; Jona Saemundsdottir; Olof Olafsdottir; Larus J Gudmundsson; Gyda Bjornsdottir; Kristleifur Kristjansson; Halla Skuladottir; Helgi J Isaksson; Tomas Gudbjartsson; Gregory T Jones; Thomas Mueller; Anders Gottsäter; Andrea Flex; Katja K H Aben; Femmie de Vegt; Peter F A Mulders; Dolores Isla; Maria J Vidal; Laura Asin; Berta Saez; Laura Murillo; Thorsteinn Blondal; Halldor Kolbeinsson; Jon G Stefansson; Ingunn Hansdottir; Valgerdur Runarsdottir; Roberto Pola; Bengt Lindblad; Andre M van Rij; Benjamin Dieplinger; Meinhard Haltmayer; Jose I Mayordomo; Lambertus A Kiemeney; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Daniel F Gudbjartsson; Jeffrey R Gulcher; Steinn Jonsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

6.  Antioxidants protect against increased risk of atherosclerosis induced by exposure to cigarette smoke: Histological and biochemical study.

Authors:  Soad Shaker Ali; Nasra Naeim Ayuob; Abeer Khaled Al Ansary; Ekram Rage Soluman
Journal:  Saudi J Biol Sci       Date:  2012-03-29       Impact factor: 4.219

7.  Patient Characteristics and Comorbidities Influence Walking Distances in Symptomatic Peripheral Arterial Disease: A Large One-Year Physiotherapy Cohort Study.

Authors:  Sarah Dörenkamp; Ilse Mesters; Rob de Bie; Joep Teijink; Gerard van Breukelen
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

8.  Screening of peripheral arterial disease in primary health care.

Authors:  Zsombor Tóth-Vajna; Gergely Tóth-Vajna; Zsuzsanna Gombos; Brigitta Szilágyi; Zoltán Járai; Márton Berczeli; Péter Sótonyi
Journal:  Vasc Health Risk Manag       Date:  2019-08-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.